Fosavance European Union - English - EMA (European Medicines Agency)

fosavance

n.v. organon - alendronic acid, colecalciferol - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of postmenopausal osteoporosis in patients at risk of vitamin-d insufficiency.fosavance reduces the risk of vertebral and hip fractures.

Alendronate/Colecalciferol Teva 70 mg/2800 IU tablets Ireland - English - HPRA (Health Products Regulatory Authority)

alendronate/colecalciferol teva 70 mg/2800 iu tablets

teva pharma b.v. - vitamin d3; alendronic acid - tablet - 70 mg/2800 international unit(s) - bisphosphonates, combinations; alendronic acid and colecalciferol

Alendronate/Colecalciferol Teva 70 mg/5600 IU tablets Ireland - English - HPRA (Health Products Regulatory Authority)

alendronate/colecalciferol teva 70 mg/5600 iu tablets

teva pharma b.v. - vitamin d3; alendronic acid - tablet - 70 mg/5600 international unit(s) - bisphosphonates, combinations; alendronic acid and colecalciferol

Fosamax Plus 70 mg/140 ug alendronic acid 70 mg (as alendronate sodium) and colecalciferol 140 micrograms tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fosamax plus 70 mg/140 ug alendronic acid 70 mg (as alendronate sodium) and colecalciferol 140 micrograms tablet blister pack

organon pharma pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.1387 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; lactose; croscarmellose sodium; purified water; gelatin; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; medium chain triglycerides - the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.

Fosamax Plus Once Weekly alendronic acid 70 mg (as alendronate sodium) and colecalciferol 70 micrograms tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fosamax plus once weekly alendronic acid 70 mg (as alendronate sodium) and colecalciferol 70 micrograms tablet blister pack

organon pharma pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.0693 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; lactose; microcrystalline cellulose; magnesium stearate; purified water; gelatin; aluminium starch octenylsuccinate; aluminium sodium silicate; sucrose; medium chain triglycerides - the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.

Alendronic acid/colecalciferol New Zealand - English - Medsafe (Medicines Safety Authority)

alendronic acid/colecalciferol

teva pharma (new zealand) limited - alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg; colecalciferol 0.14mg;   - film coated tablet - active: alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg colecalciferol 0.14mg   excipient: butylated hydroxytoluene colloidal silicon dioxide copovidone magnesium stearate mannitol medium-chain triglycerides microcrystalline cellulose   opadry white 85f18378 purified water sucrose - indicated for the treatment of osteoporosis in select patients where viatmin d supplementation is recommended.

Alendronic acid/colecalciferol New Zealand - English - Medsafe (Medicines Safety Authority)

alendronic acid/colecalciferol

teva pharma (new zealand) limited - alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg; colecalciferol 0.07mg;   - film coated tablet - active: alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg colecalciferol 0.07mg   excipient: butylated hydroxytoluene colloidal silicon dioxide copovidone magnesium stearate mannitol medium-chain triglycerides microcrystalline cellulose   opadry white 85f18378 purified water sucrose - indicated for the treatment of osteoporosis in select patients where viatmin d supplementation is recommended.